Intravenous Buprenorphine Micro-dosing Induction in a Patient on Methadone Treatment: A Case Report.
作者信息
Crane Kelly, Snead Jessica, Stanley Robert, Avery Jonathan, Ghosh Sumantra Monty, Mints Gregory
机构信息
Department of Medicine, Weill Cornell Medical College, New York, NY.
Department of Pharmacy, New York-Presbyterian Hospital, New York, NY.
出版信息
J Acad Consult Liaison Psychiatry. 2021 Mar-Apr;62(2):243-247. doi: 10.1016/j.psym.2020.07.004. Epub 2020 Jul 25.
Abstract
摘要
相似文献
1
Intravenous Buprenorphine Micro-dosing Induction in a Patient on Methadone Treatment: A Case Report.美沙酮治疗患者静脉注射丁丙诺啡微剂量诱导：一例报告
J Acad Consult Liaison Psychiatry. 2021 Mar-Apr;62(2):243-247. doi: 10.1016/j.psym.2020.07.004. Epub 2020 Jul 25.
2
Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.阿片类药物依赖的医学治疗中丁丙诺啡和美沙酮方案：选择合适的药物治疗。
Am J Addict. 2010 Nov-Dec;19(6):557-68. doi: 10.1111/j.1521-0391.2010.00086.x. Epub 2010 Sep 21.
3
Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.丁丙诺啡依赖者阿片类药物戒断症状的评估与管理。
Br J Addict. 1992 Jan;87(1):55-62. doi: 10.1111/j.1360-0443.1992.tb01900.x.
4
Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting.在退伍军人事务部的门诊环境中，利用微量滴定方案从美沙酮快速过渡到丁丙诺啡。
J Addict Med. 2020 Sep/Oct;14(5):e271-e273. doi: 10.1097/ADM.0000000000000618.
5
Neonatal abstinence syndrome after methadone or buprenorphine exposure.美沙酮或丁丙诺啡暴露后的新生儿戒断综合征。
N Engl J Med. 2010 Dec 9;363(24):2320-31. doi: 10.1056/NEJMoa1005359.
6
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.醋酸左美沙朵、丁丙诺啡和美沙酮治疗阿片类物质依赖的比较
N Engl J Med. 2000 Nov 2;343(18):1290-7. doi: 10.1056/NEJM200011023431802.
7
Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report.门诊环境中应用舌下丁丙诺啡/纳洛酮快速微诱导技术治疗阿片类药物使用障碍：病例报告。
J Addict Dis. 2022 Jul-Sep;40(3):439-443. doi: 10.1080/10550887.2021.1996153. Epub 2022 Jan 24.
8
Is there a better way to match patients to opioid maintenance treatment: a case report.是否存在更好的方法来为患者匹配阿片类药物维持治疗：病例报告
Am J Addict. 2009 Mar-Apr;18(2):180-1. doi: 10.1080/10550490802544102.
9
Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.静脉内滥用美沙酮、丁丙诺啡和丁丙诺啡-纳洛酮在接受阿片类药物维持治疗的患者中的横断面多中心研究。
Eur Addict Res. 2019;25(1):10-19. doi: 10.1159/000496112. Epub 2019 Jan 9.
10
Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.接受丁丙诺啡、美沙酮或纳曲酮维持治疗的阿片类物质使用障碍患者的围手术期注意事项
Anesthesiol Clin. 2018 Sep;36(3):345-359. doi: 10.1016/j.anclin.2018.04.002. Epub 2018 Jul 11.
引用本文的文献
1
Initiation of Low-Dose Intravenous Buprenorphine for Opioid Use Disorder: A Case Series and Literature Review.低剂量静脉注射丁丙诺啡治疗阿片类物质使用障碍：病例系列及文献综述
Cureus. 2024 Aug 28;16(8):e68007. doi: 10.7759/cureus.68007. eCollection 2024 Aug.
2
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series.低剂量 IV 丁丙诺啡诱导治疗合并疼痛的阿片类药物使用障碍患者：一项回顾性病例系列研究。
Addict Sci Clin Pract. 2023 Jun 1;18(1):38. doi: 10.1186/s13722-023-00392-z.
3
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.阿片类物质使用障碍和疼痛管理中丁丙诺啡的起始策略：系统评价。
Pharmacotherapy. 2022 May;42(5):411-427. doi: 10.1002/phar.2676. Epub 2022 Mar 25.
4
Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients-A Critical Review.阿片类药物依赖患者从完全μ阿片受体激动剂转换为丁丙诺啡的批判性综述
Front Pharmacol. 2021 Nov 23;12:718811. doi: 10.3389/fphar.2021.718811. eCollection 2021.
5
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder.丁丙诺啡微诱导治疗阿片类药物使用障碍的药理学。
Clin Drug Investig. 2021 May;41(5):425-436. doi: 10.1007/s40261-021-01032-7. Epub 2021 Apr 5.
本文引用的文献
1
Remote buprenorphine-naloxone initiation as an essential service for people with chronic pain and opioid dependence during the COVID-19 pandemic: Case reports, clinical pathways, and implications for the future.在2019年冠状病毒病大流行期间，远程启动丁丙诺啡-纳洛酮作为慢性疼痛和阿片类药物依赖患者的一项基本服务：病例报告、临床路径及对未来的启示
Can J Pain. 2020 Sep 15;4(1):224-235. doi: 10.1080/24740527.2020.1795634.
2
Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.从高剂量、长期阿片类药物转换为丁丙诺啡：病例系列
Ann Intern Med. 2020 Jul 7;173(1):70-71. doi: 10.7326/L19-0725. Epub 2020 Apr 7.
3
Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.丁丙诺啡用于逆转阿片类药物依赖患者美沙酮过量所致呼吸抑制：一项前瞻性随机试验。
Crit Care. 2020 Feb 7;24(1):44. doi: 10.1186/s13054-020-2740-y.
4
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach.病例报告：通过微剂量方案和积极外展成功诱导丁丙诺啡/纳洛酮。
Addict Sci Clin Pract. 2020 Jan 15;15(1):2. doi: 10.1186/s13722-020-0177-x.
5
Case Series: Limited Opioid Withdrawal With Use of Transdermal Buprenorphine to Bridge to Sublingual Buprenorphine in Hospitalized Patients.病例系列：经皮丁丙诺啡过渡至舌下丁丙诺啡用于住院患者的阿片类药物戒断：有限的阿片类药物戒断。
Am J Addict. 2020 Jan;29(1):73-76. doi: 10.1111/ajad.12964. Epub 2019 Oct 18.
6
Buprenorphine in the United States: Motives for abuse, misuse, and diversion.丁丙诺啡在美国：滥用、误用和转移的动机。
J Subst Abuse Treat. 2019 Sep;104:148-157. doi: 10.1016/j.jsat.2019.07.005. Epub 2019 Jul 12.
7
Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.使用微量剂量方案，在不进行阿片类药物戒断期的情况下，将患有阿片类药物使用障碍的住院患者从美沙酮转为丁丙诺啡。
Pharmacotherapy. 2019 Oct;39(10):1023-1029. doi: 10.1002/phar.2313. Epub 2019 Aug 15.
8
Rapid micro-induction of buprenorphine/naloxone for opioid use disorder in an inpatient setting: A case series.在住院环境中快速微量诱导丁丙诺啡/纳洛酮治疗阿片类药物使用障碍：病例系列研究。
Am J Addict. 2019 Jul;28(4):262-265. doi: 10.1111/ajad.12869. Epub 2019 Mar 22.
9
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations.丁丙诺啡药理学综述：透黏膜和长效制剂的更新。
J Addict Med. 2019 Mar/Apr;13(2):93-103. doi: 10.1097/ADM.0000000000000457.
10
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.长效纳曲酮与丁丙诺啡-纳洛酮预防阿片类药物复发的比较效果（X:BOT）：一项多中心、开放标签、随机对照试验。
Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14.
Zotero 插件